Bayer boasts the largest research and development budget of the entire chemical and pharmaceutical industry in our home country, Germany. We support political frameworks that foster innovation. Since providing new benefits to society must be rewarded, this includes secure knowledge protection worldwide. In Germany, Bayer advocates the introduction of a tax credit for R&D investments.
Zoom imageA development laboratory for biological active substances at Bayer HealthCare in Wuppertal, Germany.
Innovative research is at the center of Bayer’s business strategy – in line with our slogan “
Science For A Better Life”. Bayer has the biggest budget for research and development (R&D) in the entire German chemical-pharmaceutical industry.
We support the efforts of the EU member states to substantially increase R&D spending to 3% of gross national product. Both Europe and Germany still have a long way to go before they reach this target.
A comprehensive innovation strategy is required to fully exploit the innovation potential that exists in this country. It should focus on three areas.